trending Market Intelligence /marketintelligence/en/news-insights/trending/WXm2Cbbp6BMO6YvKvepR3A2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Relevium cancels equity purchase in CannaKids, enters license deal instead

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Relevium cancels equity purchase in CannaKids, enters license deal instead

Relevium Technologies Inc. said it is no longer acquiring an equity stake in CK Properties and its CannaKids brand under a previous deal.

CK Properties develops medical cannabis for pediatric and adult applications. Relevium previously agreed to acquire an initial 25% of the outstanding shares of CK Properties and CannaKids and the Canadian exclusive rights for the brand for US$2.7 million.

Instead, the Montreal-based healthcare equipment company will buy an exclusive license for the CannaKids intellectual property in Canada for $1.1 million. The renegotiated deal consideration includes $800,000 in shares and $300,000 in cash.

CK Properties will also be eligible for a 13% royalty on sales under the renegotiated license deal.

Relevium expects the transaction to close upon approval by the TSX Venture Exchange.